» Articles » PMID: 16456541

B56-containing PP2A Dephosphorylate ERK and Their Activity is Controlled by the Early Gene IEX-1 and ERK

Overview
Journal EMBO J
Date 2006 Feb 4
PMID 16456541
Citations 114
Authors
Affiliations
Soon will be listed here.
Abstract

The protein phosphatase 2A (PP2A) acts on several kinases in the extracellular signal-regulated kinase (ERK) signaling pathway but whether a specific holoenzyme dephosphorylates ERK and whether this activity is controlled during mitogenic stimulation is unknown. By using both RNA interference and overexpression of PP2A B regulatory subunits, we show that B56, but not B, family members of PP2A increase ERK dephosphorylation, without affecting its activation by MEK. Induction of the early gene product and ERK substrate IEX-1 (ier3) by growth factors leads to opposite effects and reverses B56-PP2A-mediated ERK dephosphorylation. IEX-1 binds to B56 subunits and pERK independently, enhances B56 phosphorylation by ERK at a conserved Ser/Pro site in this complex and triggers dissociation from the catalytic subunit. This is the first demonstration of the involvement of B56-containing PP2A in ERK dephosphorylation and of a B56-specific cellular protein inhibitor regulating its activity in an ERK-dependent fashion. In addition, our results raise a new paradigm in ERK signaling in which ERK associated to a substrate can transphosphorylate nearby proteins.

Citing Articles

Enhanced kinase translocation reporters for simultaneous real-time measurement of PKA, ERK, and calcium.

Tsai S, Gong Y, Dabbs A, Zahra F, Xu J, Geske A J Biol Chem. 2025; 301(3):108183.

PMID: 39814226 PMC: 11871455. DOI: 10.1016/j.jbc.2025.108183.


KRAS-mediated upregulation of CIP2A promotes suppression of PP2A-B56α to initiate pancreatic cancer development.

Tinsley S, Chianis E, Shelley R, Mall G, Dhiman A, Baral G Oncogene. 2024; 43(50):3673-3687.

PMID: 39443726 DOI: 10.1038/s41388-024-03196-w.


Enhanced kinase translocation reporters for simultaneous real-time measurement of PKA, ERK, and Ca.

Tsai S, Gong Y, Dabbs A, Zahra F, Xu J, Geske A bioRxiv. 2024; .

PMID: 39411162 PMC: 11475874. DOI: 10.1101/2024.09.30.615856.


Unraveling the CDK9/PP2A/ERK Network in Transcriptional Pause Release and Complement Activation in KRAS-mutant Cancers.

Wang Y, Xu L, Ling L, Yao M, Shi S, Yu C Adv Sci (Weinh). 2024; 11(41):e2404926.

PMID: 39254172 PMC: 11538672. DOI: 10.1002/advs.202404926.


KRAS-mediated upregulation of CIP2A promotes suppression of PP2A-B56α to initiate pancreatic cancer development.

Tinsley S, Shelley R, Mall G, Chianis E, Dhiman A, Baral G bioRxiv. 2024; .

PMID: 38826439 PMC: 11142131. DOI: 10.1101/2023.07.01.547283.


References
1.
Seeling J, Miller J, Gil R, Moon R, White R, Virshup D . Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A. Science. 1999; 283(5410):2089-91. DOI: 10.1126/science.283.5410.2089. View

2.
Xu Z, Williams B . The B56alpha regulatory subunit of protein phosphatase 2A is a target for regulation by double-stranded RNA-dependent protein kinase PKR. Mol Cell Biol. 2000; 20(14):5285-99. PMC: 85978. DOI: 10.1128/MCB.20.14.5285-5299.2000. View

3.
Adams D, Coffee Jr R, Zhang H, Pelech S, Strack S, Wadzinski B . Positive regulation of Raf1-MEK1/2-ERK1/2 signaling by protein serine/threonine phosphatase 2A holoenzymes. J Biol Chem. 2005; 280(52):42644-54. DOI: 10.1074/jbc.M502464200. View

4.
Garcia J, Ye Y, Arranz V, Letourneux C, Pezeron G, Porteu F . IEX-1: a new ERK substrate involved in both ERK survival activity and ERK activation. EMBO J. 2002; 21(19):5151-63. PMC: 129026. DOI: 10.1093/emboj/cdf488. View

5.
Li M, Guo H, Damuni Z . Purification and characterization of two potent heat-stable protein inhibitors of protein phosphatase 2A from bovine kidney. Biochemistry. 1995; 34(6):1988-96. DOI: 10.1021/bi00006a020. View